[Multiple sclerosis].
Tanosaki
Masato
M
Third Department of Internal Medicine, Hirosaki University School of Medicine.
Matsunaga
Muneo
M
D015551:Autoimmunity; D003131:Combined Modality Therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016899:Interferon-beta / Q000627:therapeutic use; D007937:Leukapheresis; D009103:Multiple Sclerosis / Q000145:classification / Q000276:immunology / Q000628:therapy*; D020528:Multiple Sclerosis, Chronic Progressive / Q000628:therapy; D010951:Plasma Exchange / Q000379:methods; D011239:Prednisolone / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D013601:T-Lymphocytes / Q000276:immunology
D007166:Immunosuppressive Agents; D016899:Interferon-beta; D011239:Prednisolone